Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion type Assertion NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_head.
- NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion description "[EGFR and FCGR3A germline polymorphisms are associated with PFS in KRAS wild-type mCRC patients treated with cetuximab, bevacizumab and chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_provenance.
- NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion evidence source_evidence_literature NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_provenance.
- NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion SIO_000772 20418097 NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_provenance.
- NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion wasDerivedFrom gad-20130706 NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_provenance.
- NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_assertion wasGeneratedBy ECO_0000203 NP64353.RAfXUZ2nCIAfZ8oXsLLsQWB_UFh4mVgZJUNntSuxZSVm8130_provenance.